RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
49 hedge funds and large institutions have $585M invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+8
Holders Change %
+19.51%
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
9
Reduced
10
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GPP
51
Great Point Partners
Greenwich,
Connecticut
| – | -$4.57M | -250,000 | Closed |
|
52
Millennium Management
New York
| – | -$3.4M | -186,157 | Closed |
|
53
Wellington Management Group
Boston,
Massachusetts
| – | -$2.74M | -150,193 | Closed |
|
|
MWNA
54
Marshall Wace North America
New York
| – | -$1.45M | -79,171 | Closed |
|
55
Goldman Sachs
New York
| – | -$1.08M | -59,083 | Closed |
|
56
Alyeska Investment Group
Chicago,
Illinois
| – | -$913K | -50,000 | Closed |
|
57
TD Asset Management
Toronto,
Ontario, Canada
| – | -$629K | -34,465 | Closed |
|
|
PCM
58
Pinz Capital Management
New York
| – | -$572K | -31,300 | Closed |
|
|
SCM
59
Silverarc Capital Management
Boston,
Massachusetts
| – | -$274K | -15,000 | Closed |
|
|
CCM
60
CAAS Capital Management
New York
| – | -$274K | -15,000 | Closed |
|
|
HP
61
Hound Partners
New York
| – | -$188K | -10,292 | Closed |
|
|
MS
62
Maven Securities
St Helier,
Jersey
| – | -$152K | -8,333 | Closed |
|
63
UBS Group
Zurich,
Switzerland
| – | -$14K | -776 | Closed |
|